Obesity, vitamin D status and physical activity: 1,25(OH)2D as a potential marker of vitamin D deficiency in obese subjects.


Journal

Panminerva medica
ISSN: 1827-1898
Titre abrégé: Panminerva Med
Pays: Italy
ID NLM: 0421110

Informations de publication

Date de publication:
Jun 2020
Historique:
entrez: 10 6 2020
pubmed: 10 6 2020
medline: 7 4 2021
Statut: ppublish

Résumé

Obesity has been regarded to be protective against fracture in spite of its association with low levels of vitamin D. Vitamin D is the key regulator of bone metabolism and its deficiency contributes to higher level of parathyroid hormone (PTH), leading to the activation of bone turnover. We studied 161 subjects of which 65 were young healthy subjects and 96 were elderly subjects. We measured creatinine, 25(OH)D, 1,25(OH)2D, PTH, albumin, and calcium plasma levels, we evaluated physical activity, and we calculated BMI. A sub-cohort of elderly subjects also underwent DXA scans. Overweight and obese subjects, as well as underweight ones, had lower levels of vitamin D but normal serum concentrations of 1,25(OH)2D and PTH was higher in underweight and obese subjects. Moreover, we found a nonlinear relationship between body mass index (BMI) and PTH with a significant U-shaped exponential regression. Regardless of BMI, 25(OH)D mean levels were higher in subjects who practice physical activity. These findings suggest that physical activity and BMI had a significant effect on the metabolism of bone and vitamin D, but the effect of BMI was different in underweight, normal weight or obese subjects. In obesity the real vitamin D deficiency could be estimate by serum 1,25(OH)2D concentrations whose lower levels contribute to the higher PTH production and consequently to bone loss and to a greater fracture risk.

Sections du résumé

BACKGROUND BACKGROUND
Obesity has been regarded to be protective against fracture in spite of its association with low levels of vitamin D. Vitamin D is the key regulator of bone metabolism and its deficiency contributes to higher level of parathyroid hormone (PTH), leading to the activation of bone turnover.
METHODS METHODS
We studied 161 subjects of which 65 were young healthy subjects and 96 were elderly subjects. We measured creatinine, 25(OH)D, 1,25(OH)2D, PTH, albumin, and calcium plasma levels, we evaluated physical activity, and we calculated BMI. A sub-cohort of elderly subjects also underwent DXA scans.
RESULTS RESULTS
Overweight and obese subjects, as well as underweight ones, had lower levels of vitamin D but normal serum concentrations of 1,25(OH)2D and PTH was higher in underweight and obese subjects. Moreover, we found a nonlinear relationship between body mass index (BMI) and PTH with a significant U-shaped exponential regression. Regardless of BMI, 25(OH)D mean levels were higher in subjects who practice physical activity.
CONCLUSIONS CONCLUSIONS
These findings suggest that physical activity and BMI had a significant effect on the metabolism of bone and vitamin D, but the effect of BMI was different in underweight, normal weight or obese subjects. In obesity the real vitamin D deficiency could be estimate by serum 1,25(OH)2D concentrations whose lower levels contribute to the higher PTH production and consequently to bone loss and to a greater fracture risk.

Identifiants

pubmed: 32515572
pii: S0031-0808.20.03770-2
doi: 10.23736/S0031-0808.20.03770-2
doi:

Substances chimiques

Biomarkers 0
Vitamin D 1406-16-2
1,25-dihydroxyvitamin D 66772-14-3

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

83-92

Auteurs

Alessia Valentini (A)

Department of Systems Medicine, Tor Vergata University, Rome, Italy.

Marco A Perrone (MA)

Division of Cardiology, Tor Vergata University, Rome, Italy - marco.perrone01@gmail.com.
University Sports Center, Tor Vergata University, Rome, Italy.

Maria A Cianfarani (MA)

Department of Systems Medicine, Tor Vergata University, Rome, Italy.

Umberto Tarantino (U)

Department of Orthopedics and Traumatology, Tor Vergata University, Rome, Italy.

Renato Massoud (R)

Department of Experimental Medicine, Tor Vergata University, Rome, Italy.

Giuseppe Merra (G)

Department of Experimental Medicine, Tor Vergata University, Rome, Italy.

Sergio Bernardini (S)

University Sports Center, Tor Vergata University, Rome, Italy.
Department of Experimental Medicine, Tor Vergata University, Rome, Italy.

Howard A Morris (HA)

School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia.

Aldo Bertoli (A)

Department of Systems Medicine, Tor Vergata University, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH